Publicaciones en colaboración con investigadores/as de Universidade de Santiago de Compostela (21)

2023

  1. Mitochondrial RNA methyltransferase TRMT61B is a new, potential biomarker and therapeutic target for highly aneuploid cancers

    Cell Death and Differentiation, Vol. 30, Núm. 1, pp. 37-53

  2. The outcome of boosting mitochondrial activity in alcohol-associated liver disease is organ-dependent

    Hepatology (Baltimore, Md.), Vol. 78, Núm. 3, pp. 878-895

2022

  1. Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH)

    Gastroenterologia y Hepatologia, Vol. 45, Núm. 9, pp. 724-734

  2. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

2021

  1. Changes in the Objective Structured Clinical Examination (OSCE) of University Schools of Medicine during COVID-19. Experience with a computer-based case simulation OSCE (CCS-OSCE)

    Revista Clinica Espanola, Vol. 221, Núm. 8, pp. 456-463

  2. Neddylation inhibition ameliorates steatosis in NAFLD by boosting hepatic fatty acid oxidation via the DEPTOR-mTOR axis

    Molecular Metabolism, Vol. 53

2019

  1. Vagal afferents contribute to sympathoexcitation-driven metabolic dysfunctions

    Journal of Endocrinology, Vol. 240, Núm. 3, pp. 483-496

2013

  1. Early growth hormone (GH) treatment promotes relevant motor functional improvement after severe frontal cortex lesion in adult rats

    Behavioural Brain Research, Vol. 247, pp. 48-58

2009

  1. Bile acids: Chemistry, physiology, and pathophysiology

    World Journal of Gastroenterology, Vol. 15, Núm. 7, pp. 804-816

  2. In vitro inhibition of OATP-mediated uptake of phalloidin using bile acid derivatives

    Toxicology and Applied Pharmacology, Vol. 239, Núm. 1, pp. 13-20

  3. Protective effect of bile acid derivatives in phalloidin-induced rat liver toxicity

    Toxicology and Applied Pharmacology, Vol. 239, Núm. 1, pp. 21-28

2003

  1. Effect of ursodeoxycholic acid on the impairment induced by maternal cholestasis in the rat placenta-maternal liver tandem excretory pathway

    Journal of Pharmacology and Experimental Therapeutics, Vol. 305, Núm. 2, pp. 515-524

1990

  1. K-channel blocking drugs induce histamine release and <sup>45</sup>Ca uptake in isolated mast cells

    International Archives of Allergy and Immunology, Vol. 92, Núm. 2, pp. 162-167

1988

  1. Dual effect of dihydropyridines on 45Ca uptake induced by the K+ —channel blocker 4‐aminopyridin on mast cells

    Journal of Cellular Physiology, Vol. 137, Núm. 2, pp. 378-383

  2. Effect of colchicine on histamine secretion and calcium uptake in mast cells

    Revista española de fisiología, Vol. 44, Núm. 1, pp. 35-40

1987

  1. Adrenergic activity on rat pleural and peritoneal mast cells. Loss of β-receptors during the purification procedure

    General Pharmacology, Vol. 18, Núm. 2, pp. 141-148

  2. Hydralazine-relaxing effect on rat aorta is not mediated through changes in ATPase activity

    Archives Internationales de Pharmacodynamie et de Therapie, Vol. 285, Núm. 1, pp. 72-79

  3. Valinomycin, a degranulating agent in rat mast cells which inhibits calcium-uptake

    Agents and Actions, Vol. 22, Núm. 3-4, pp. 189-196

1986

  1. Effect of calcium on histamine release from pleural and peritoneal mast cells induced by catechol

    Revista Espanola de Fisiologia, Vol. 42, Núm. 4, pp. 455-458

  2. SECRECION DE HISTAMINA INDUCIDA POR EL COMPUESTO 48/80 EN MASTOCITOS: REQUERIMIENTOS METABOLICOS DURANTE LA EXOCITOSIS

    Anales de la Real Academia de Farmacia, Vol. 52, Núm. 2, pp. 349-354